Table 3. The overall treatment results for the 618 women treated for GTT after a molar pregnancy.
| Low-risk FIGO 0–6 | Highrisk FIGO 7–10 | ||||
|---|---|---|---|---|---|
| Number | Success (%) | Number | Success (%) | ||
| First-line chemotherapy (579) | First-line chemotherapy (39) | ||||
| MTX/FA | 554 | 57 | MTX/FA | 3 | 0 |
| Dactinomycin | 3 | 33 | EMA–CO | 36 | 92 |
| EMA–CO | 22 | 100 | — | — | — |
| Second-line chemotherapy (238) | Second-line chemotherapy (6) | ||||
| Dactinomycin | 96 | 94 | EMA–CO | 3 | 100 |
| EMA–CO | 142 | 99 | TE/TP | 3 | 33 |
| Thirdline chemotherapy (7) | Third-line treatment (2) | ||||
| EMA–CO | 5 | 100 | Hysterectomy | 2 | 100 |
| TE/TP | 2 | 100 | |||
Abbreviations: EMA–CO=etoposide, MTX, actinomycin D, cyclophosphamide, vincristine; FA=folinic acid; FIGO=Fédération Internationale de Gynécologie et d'Obstétrique; GTT=gestational trophoblastic tumour; MTX=methotrexate; TE=taxol–etoposide; TP=taxol–cisplatin.
The table shows the outcomes separately for the 579 women in the low-risk prognostic groups and 39 high-risk patients. All the patients in both groups were cured.